| 发明名称 |
2-OXO-1-PYRROLIDINE DERIVATIVE, METHOD FOR PRODUCING THE SAME AND USE THEREOF |
| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a pharmaceutical composition especially suitable for the treatment of neurologic damage such as epilepsy, seizure disorder, manic psychosis, depression, Parkinson's disease and bronchial asthma. <P>SOLUTION: The pharmaceutical composition contains (4R) and/or (4S) diastereomer of a (2S)-2-[2-oxo-4-propylpyrrolidinyl]butanamide derivative or its pharmaceutically permissible salt. <P>COPYRIGHT: (C)2006,JPO&NCIPI</p> |
| 申请公布号 |
JP2006022108(A) |
申请公布日期 |
2006.01.26 |
| 申请号 |
JP20050217442 |
申请日期 |
2005.07.27 |
| 申请人 |
UCB SA |
发明人 |
DIFFERDING EDMOND;KENDA BENOIT;LALLEMAND BENEDICTE;MATAGNE ALAIN;MICHEL PHILIPPE;PASAU PATRICK;TALAGA PATRICE |
| 分类号 |
C07D207/27;C07D401/04;A61K31/40;A61K31/4015;A61K31/4025;A61K31/41;A61K31/4178;A61K31/4188;A61K31/4192;A61K31/4196;A61K31/422;A61K31/4245;A61K31/427;A61K31/433;A61K31/4439;A61K31/496;A61K31/497;A61K31/506;A61K31/541;A61P9/00;A61P9/06;A61P9/10;A61P11/00;A61P11/06;A61P11/08;A61P21/00;A61P25/00;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/36;A61P27/16;A61P37/08;C07B61/00;C07C237/06;C07C237/12;C07D207/26;C07D207/273;C07D207/277;C07D307/33;C07D401/06;C07D403/04;C07D403/06;C07D403/12;C07D405/04;C07D409/04;C07D413/04;C07D417/04;C07D495/04 |
主分类号 |
C07D207/27 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
